Bukwang Pharmaceuticals, LSK BioPartners, and West Coast Clinical Trials Begin Work Together in Oncology

 

West Coast Clinical Trials announced today the beginning of a partnership with Bukwang Pharma and LSK BioPartners to work on an oncology compound.  The compound being developed, YN968D1, is a small molecule antiangiogenesis compound in the same class as Avastin.  This compound has already produced some excellent Phase II data in China.

“WCCT is eager to work with Bukwang Pharmaceuticals and LSK BioPartners in the development of YN968D1 which could potentially benefit oncology patients.  In doing so, we are expanding our therapeutic expertise by deepening our Phase I trials to include oncology,  It also marks WCCT’s continued progress in partnering with Korean, Japanese, and Chinese pharmaceutical companies in providing IND, regulatory , drug development , and phase 1/2a services to these group of companies.” said Dr. Kenneth Kim, CEO of WCCT.

About West Coast Clinical Trials

WCCT is a privately owned independent Phase I-IV CRO, conveniently located near 3 major airports in Southern California. WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Asthma. Conducting trials since 1998, WCCT has been audited by the FDA and numerous pharmaceutical and biotechnology companies. WCCT’s location and access to an ethnically diverse population allows for a wide variety of study designs including ethnic bridging. With 150 beds in two locations and over 40,000 square feet, a well-trained and experienced staff, and advanced technological procedures, WCCT brings the highest quality to the pharmaceutical and biotechnology industries.

About Bukwang Pharmaceuticals

Bukwang Pharm.Co.,Ltd. is a Korea-based manufacturer and distributor of pharmaceutical products. The Company offers a range of products, including antidiabetic agents, liver disorder remedies, gastrointestinal agents, respiratory agents, cardiovascular agents, antihistamines, neuropsychotherapeutic agents, antineoplastic agents, thyroid preparations, obstetric and gynecologic agents, skin mucous membrane agents, urinary tract agent, mouth and throat products, sedative, hypnotics, calcium supplements, antidotes, cold and cough preparations, anemia preparations, analgesics, anti-inflammatory agents, antirheumatic agents, vitamines, blood modifiers, motion sickness products and others. In addition, the Company operates a research and development center.

About LSK BioPartners

LSK BioPartner, Inc. (“LSKB”) is an international healthcare product development company. LSKB is dedicated to creating and adding value to new and innovative healthcare products.  The Company is managed by industry experts who have a successful track record of developing innovative products.